Relationship of SARS-CoV-2 Pandemic with Blood Groups.
Blood group O
Blood group distribution
SARS-CoV infection
Journal
Transfusion medicine and hemotherapy : offizielles Organ der Deutschen Gesellschaft fur Transfusionsmedizin und Immunhamatologie
ISSN: 1660-3796
Titre abrégé: Transfus Med Hemother
Pays: Switzerland
ID NLM: 101176417
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
received:
14
11
2020
accepted:
28
02
2021
entrez:
28
6
2021
pubmed:
29
6
2021
medline:
29
6
2021
Statut:
ppublish
Résumé
SARS-CoV attaches to human angiotensin-converting enzyme 2 receptor with the spike protein and infects cells. It can play a direct role in infection by acting as a receptor and/or co-receptor for blood group antigens, microorganisms, parasites, and viruses. We aimed to compare the blood group distribution of patients with SARS-CoV-2 infection admitted to hospital and that of healthy donors. A total of 823 patients with a positive SARS-CoV-2 test and clinical symptoms were included in the study. The results were compared with the normal blood group distribution in the region. While the prevalence of COVID-19 in the A, B, and AB blood groups was higher than that in the healthy blood donors, it was lower in the O blood group ( Our results are in agreement with other studies suggesting that blood group O individuals are somewhat more resistant to clinically overt infection with SARS-CoV-2 than other blood groups. However, this tendency is not sufficiently established to allow special prophylaxis recommendations for non-O individuals.
Identifiants
pubmed: 34177420
doi: 10.1159/000515609
pii: tmh-0048-0161
pmc: PMC8089448
doi:
Types de publication
Journal Article
Langues
eng
Pagination
161-167Informations de copyright
Copyright © 2021 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
The authors declare no conflict of interest.
Références
Open AIDS J. 2013 Oct 18;7:47-50
pubmed: 24222813
Br J Haematol. 2020 Jul;190(2):e93-e94
pubmed: 32453863
Br J Haematol. 2020 Jul;190(1):24-27
pubmed: 32379894
J Exp Med. 1959 Aug 1;110(2):221-44
pubmed: 13673136
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
World J Gastroenterol. 2006 Feb 21;12(7):1120-4
pubmed: 16534856
Epidemiol Infect. 2010 Aug;138(8):1096-9
pubmed: 20003613
Clin Infect Dis. 1994 May;18(5):827-8
pubmed: 8075282
Infect Genet Evol. 2020 Oct;84:104485
pubmed: 32739464
Clin Infect Dis. 2020 Aug 04;:
pubmed: 32750119
Eur J Epidemiol. 1995 Apr;11(2):181-4
pubmed: 7672073
Biophys J. 2012 Jul 3;103(1):1-10
pubmed: 22828326
Lancet Respir Med. 2020 May;8(5):475-481
pubmed: 32105632
Glycobiology. 2008 Dec;18(12):1085-93
pubmed: 18818423
N Engl J Med. 2020 Feb 20;382(8):727-733
pubmed: 31978945
Curr Opin Hematol. 2010 Nov;17(6):558-64
pubmed: 20739878
BMC Cardiovasc Disord. 2020 Aug 14;20(1):373
pubmed: 32799852
Immunohematology. 2007;23(1):38-41
pubmed: 17425414
Clin Microbiol Rev. 2015 Jul;28(3):801-70
pubmed: 26085552
Transfusion. 2020 Aug;60(8):1883-1884
pubmed: 32562280
Adv Virus Res. 2011;81:85-164
pubmed: 22094080
JAMA. 2005 Mar 23;293(12):1450-1
pubmed: 15784866
Turk J Med Sci. 2020 Jun 4;50(4):679-683
pubmed: 32496734
Clin Chim Acta. 2020 Oct;509:220-223
pubmed: 32562665
Hemoglobin. 2001 May;25(2):241-5
pubmed: 11480785
Vox Sang. 2019 Jul;114(5):426-442
pubmed: 31070258